A Review Of Cost Of Illness Studies In Patients With End Stage Renal Disease.

1. Grassmann A, et al. Nephrol Dial Transplant 2005;20:2587–93. 2. Covic A, et al. Clin Nephrol 2010;74(suppl 1):S23–7. 3. US Renal Data System. 2012. Available at: http://www.usrds.org/atlas.aspx 4. Zelmer JL. Kidney Int 2007;72:1122–9. 5. Kerr M, et al. Nephrol Dial Transplant 2012;27(suppl 3):iii73–80. 6. Villa G, et al. Nephrol Dial Transplant 2011;26:3709–14. 7. Gordois A, et al. J Diabetes Complications 2004;18:18–26. 8. Janjua HS, et al. Prog Transplant 2013;23:78–83. 9. Harris A, et al. Int J Health Care Finance Econ 2007;7:113–32. 10. O’Brien JA, et al. BMC Health Serv Res 2003;3:7. 11. Durand-Zaleski I, et al. Int J Health Care Finance Econ 2007;7:171– 83. 12. Pontoriero G, et al. Int J Health Care Finance Econ 2007;7:201–15. 13. Fukuhara S, et al. Int J Health Care Finance Econ 2007;7:217–31. 14. O’Brien JA, et al.. Clin Ther 2003;25:1017–38. 15. Mau LW, et al. Am J Kidney Dis 2010;55:549–57. 16. Li R, et al. Am J Manag Care 2013;19:421–30. 17. Joyce AT, et al. Diabetes Care 2004;27:2829–35. 18. Kamal-Bahl SJ, et al. Prev Chronic Dis 2006;3:1–10. The authors thank Mick Arber for his expert insight in devising and running the searches. Country Direct healthcare Lost productivity Cost year